Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,467
Closed -$322K 895
2016
Q4
$322K Buy
11,467
+6,250
+120% +$176K 0.05% 474
2016
Q3
$143K Sell
5,217
-578
-10% -$15.8K 0.02% 665
2016
Q2
$126K Buy
+5,795
New +$126K 0.02% 687
2016
Q1
Sell
-6,849
Closed -$189K 1009
2015
Q4
$189K Hold
6,849
0.02% 659
2015
Q3
$177K Buy
6,849
+412
+6% +$10.6K 0.02% 678
2015
Q2
$160K Hold
6,437
0.01% 741
2015
Q1
$162K Sell
6,437
-651
-9% -$16.4K 0.01% 741
2014
Q4
$166K Sell
7,088
-641
-8% -$15K 0.01% 718
2014
Q3
$176K Buy
7,729
+219
+3% +$4.99K 0.01% 742
2014
Q2
$184K Hold
7,510
0.01% 738
2014
Q1
$158K Sell
7,510
-1,300
-15% -$27.4K 0.01% 850
2013
Q4
$210K Hold
8,810
0.02% 747
2013
Q3
$189K Sell
8,810
-25,540
-74% -$548K 0.02% 755
2013
Q2
$684K Buy
+34,350
New +$684K 0.06% 452

Other funds holding QGENF

First Mercantile Trust's QGENF Position: Q1 2017 in Review

First Mercantile Trust sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 11,467 shares — an estimated $322K sold.

First Mercantile Trust first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $684K in Q2 2013. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • First Mercantile Trust reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • First Mercantile Trust sold 11,467 QIAGEN NV shares in Q1 2017, an estimated $322K.
  • First Mercantile Trust first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
  • First Mercantile Trust's QIAGEN NV position peaked at $684K in Q2 2013.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on First Mercantile Trust's 13F filing for Q1 2017, filed 25 Apr 2017.